International Journal of Organ Transplantation Medicine (Jul 2010)
Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function?
Abstract
Background: Hyperlipidemia is a common problem after kidney transplantation.Objective: To uncover the real impact of post kidney transplantation hyperlipidemia on graft function and survival, and to determine whether it is just a biochemical phenomenon after using immunosuppressant or a part of disease pathology.Methods: 330 kidney transplants were managed in Sina Hospital Kidney Transplantation Unit affiliated to Tehran University of Medical Sciences, Tehran, Iran from September 1994 till February 2010. The demographiccharacteristics of the patients, causes of chronic kidney diseases, history of pretransplantation dialysis, pretransplantation comorbidities (e.g., hypertension, diabetes mellitus [DM], hyperlipidemia and coronary artery disease), rejection episodes, status of infection with cytomegalous virus [CMV], post-transplantationDM, hyperlipidemia, ischemic heart disease [IHD], and graft and patient survival were recorded. A serum creatinine level >2 mg/dL was considered as “graft deterioration,” and return to dialysis as “graft loss.” According to the presence or absence of post kidney transplantation hypercholesterolemia (>200 mg/dL) or hypertriglyceridemia (>200 mg/dL), the patients were classified into “hyperlipidemic” or “non-hyperlipidemic.”The presence of clinical or paraclinical coronary artery disease was also determined in both groups.Results: The incidence of hyperlipidemia elevated from 8% to 50% before and after transplantation. 2.7% developed clinical IHD. 13% of hyperlipidemics and 22% of non-hyperlipidemics developed graft deterioration.Among hyperlipidemics with deteriorated grafts 40% had premorbid diseases, 68% had CMV infectionand 82% had hypertension. Only 22% had previous acute rejection and 27% received deceased kidney transplant.Conclusions: post kidney transplantation hyperlipidemia is just an associated phenomenon secondary to the use of immunosuppressant medications, which have no obvious impact on renal graft function and can be easily controlled by instituting dietary modifications and use of modern antilipid medications. Post kidneytransplantation CMV infection and hypertension are considered as the main threatening risk for renal graft—even more dangerous than acute or chronic rejections.
